Clinical Trial Update: Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial in China evaluating virus-specific cytotoxic T lymphocytes to prophylactically prevent and therapeutically treat Epstein-Barr v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• Virus-Specific Cytotoxic T-Lymphocytes

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Viral Infection | Phase 1 | Status: UNKNOWN